Aquestive Therapeutics, Inc. (AQST)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 11:08AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 306.34M |
| Enterprise Value | 315.79M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.08 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 6.24 |
| Enterprise Value/EBITDA | 267.17 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.91 |
| 52-Week Change 3 | 71.68% |
| S&P500 52-Week Change 3 | 23.57% |
| 52 Week High 3 | 6.2300 |
| 52 Week Low 3 | 1.2510 |
| 50-Day Moving Average 3 | 4.1858 |
| 200-Day Moving Average 3 | 2.4943 |
Share Statistics
| Avg Vol (3 month) 3 | 2.84M |
| Avg Vol (10 day) 3 | 3.24M |
| Shares Outstanding 5 | 91.04M |
| Implied Shares Outstanding 6 | 89.97M |
| Float 8 | 65.11M |
| % Held by Insiders 1 | 5.00% |
| % Held by Institutions 1 | 34.56% |
| Shares Short (Apr 15, 2024) 4 | 4.01M |
| Short Ratio (Apr 15, 2024) 4 | 1.22 |
| Short % of Float (Apr 15, 2024) 4 | 5.35% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 4.46% |
| Shares Short (prior month Mar 15, 2024) 4 | 2.32M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -15.56% |
| Operating Margin (ttm) | -29.61% |
Management Effectiveness
| Return on Assets (ttm) | -16.49% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 50.58M |
| Revenue Per Share (ttm) | 0.83 |
| Quarterly Revenue Growth (yoy) | 23.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | -13.73M |
| Net Income Avi to Common (ttm) | -7.87M |
| Diluted EPS (ttm) | -0.1300 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 23.87M |
| Total Cash Per Share (mrq) | 0.33 |
| Total Debt (mrq) | 33.32M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.24 |
| Book Value Per Share (mrq) | -1.55 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6.38M |
| Levered Free Cash Flow (ttm) | -16.22M |
© 2024 Yahoo. All rights reserved.